NVS eschewed the apparently mandated 'patent dance' for biosimilars and lost in both lower courts as a result. This case overturns those rulings and says NVS followed the correct approach after all. See Message 111544783 for background.
“It is possible to be a normal decent person and yet to be fully alive.” - George Orwell
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.